Search Browse Earnings

uniQure N.V. — SlamSEC

uniQure N.V.

Nasdaq:QURE

Pharmaceutical Preparations·AMSTERDAM

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$10.6M

+72.3% YoY

FY 2017

Adj. EBITDA

-$271.0M

-2561.6% margin

FY 2025

Net Income

-$308.5M

-2916.2% margin

FY 2025

EPS (Diluted)

-$6.47

FY 2025

Stock Price

$17.56

-3.9%

2026-03-11

52W Range

$7.76 – $71.50

P/E Ratio

-2.7x

Market Cap

$1.1B

Cash

$241.4M

FY 2025

Total Debt

$51.3M

FY 2025

Net Cash

$190.0M

FY 2025

Enterprise Value

$908.0M

Debt / EBITDA

0.7x

FY 2017

EV / EBITDA

-3.4x

Employees

202

FY 2017

CEO

Kapusta Matthew C

CFO

Klemt Christian